Biofourmis's workforce strategy between 2020 and 2026, as evidenced by the available data, is primarily characterized by a significant global workforce reduction implemented on July 1, 2023. This strategic maneuver involved a substantial cut of 120 employees worldwide, with 48 of these personnel adjustments specifically impacting the company's U.S. operations. This singular, documented event stands as the most prominent indicator of the firm's staffing trajectory within the specified six-year window. While the precise rationale for this reduction, such as a drive for operational efficiency or a strategic pivot towards artificial intelligence, is not detailed in the provided information, the action itself suggests a decisive effort to optimize resources or realign organizational priorities during mid-2023. The absence of further data points, including any prior expansion phases, subsequent hiring freezes, or additional workforce adjustments, limits the scope for a comprehensive trend-based analysis across the entire 2020-2026 period. Consequently, broader patterns of growth or contraction, or any specific developments anticipated for 2026, cannot be discerned or projected from the current dataset, leaving the 2023 reduction as the sole definitive insight into Biofourmis's recent workforce management.